Gastroenterologist · AI in Healthcare · Educator · Advocate · Entrepreneur

Dr Ray
Boyapati

Senior Gastroenterologist & IBD Specialist at Peninsula Health. Chief Clinical Officer at Lyrebird Health. Co-founder of MedEntry. Bridging clinical medicine, artificial intelligence, and medical education.

Dr Ray Boyapati headshot
RACP GESA Monash University Peninsula Health MedEntry Lyrebird Health GENIUS IBUS AIDH MSIA RACP GESA Monash University Peninsula Health MedEntry Lyrebird Health GENIUS IBUS AIDH MSIA
Dr Ray Boyapati

Meet Dr Ray Boyapati

I'm a clinician-researcher and entrepreneur working at the intersection of gastroenterology, health technology, and medical education. As a Senior Gastroenterologist at Peninsula Health, I specialise in inflammatory bowel disease and perform endoscopy as well as intestinal ultrasound.

As Chief Clinical Officer at Lyrebird Health, I bring clinical rigour to AI-powered clinical documentation - stress-testing AI against real clinical practice daily. I'm also a member of the AIDH, MSIA and ADHA Expert Advisory Group for AI, contributing to national conversation and policy on artificial intelligence in healthcare.

In 2002, I co-founded MedEntry, now Australia's leading medical school entry preparation company, which has helped hundreds of thousands of young people launch careers in health across Australia, New Zealand, the UK, and Ireland.

What I Do

01

Clinical Medicine & Advocacy

Senior Gastroenterologist and IBD Specialist at Peninsula Health. Subspecialty expertise in Crohn's disease, ulcerative colitis, and gastrointestinal ultrasound. Chair of the GESA IBD Faculty, advocating for clinician and patient access at the national and parliamentary level through GESA.

Get in touch →
02

Digital Healthcare & AI

Chief Clinical Officer at Lyrebird Health. Clinical governance and safety oversight, clinical workflow integration, and AI model validation for healthcare AI products. Bridging the gap between technology's promise and the reality of frontline clinical care.

Get in touch →
03

Education & Entrepreneurship

Co-founder of MedEntry, a global leader in medical school entry preparation with students across Australia, UK, Ireland and New Zealand. Adjunct Senior Lecturer at Monash University. Researcher, academic supervisor and clinical mentor.

Get in touch →
Dr Ray Boyapati teaching a packed lecture hall

Teaching the next generation of doctors

Qualifications & Roles

Qualifications

  • MBBS (Honours I) — Monash University
  • MD (Doctor of Medicine) — University of Edinburgh
  • FRACP — Royal Australasian College of Physicians
  • FGESA — Gastroenterological Society of Australia

Current Roles

  • Chief Clinical Officer — Lyrebird Health
  • Senior Gastroenterologist — Peninsula Health
  • Adjunct Senior Lecturer — Monash University
  • IBD Faculty Chair — GESA
  • Co-founder & CEO — MedEntry

Memberships

  • Gastroenterological Society of Australia (GESA)
  • Royal Australasian College of Physicians (RACP)
  • European Crohn's & Colitis Organisation (ECCO)
  • International Bowel Ultrasound Group (IBUS)
  • Gastroenterology Network of Intestinal Ultrasound (GENIUS)
  • Australasian Institute of Digital Health (AIDH)
  • Medical Software Industry Association (MSIA)

Invited Presentations & Keynotes

Available for keynotes, panels, and expert commentary on IBD, AI in healthcare, clinical innovation, and medical education.

2025

World Congress of Gastroenterology (WCOG) @ AGW 2025, Melbourne

Invited presenter, 'IBD State of the Nation' & Session Chair at the international congress

2026

Digital Health Festival, Melbourne

Keynote presentation with Lyrebird Health founder on AI in clinical documentation

2026

CCA IBD Innovation, Parliament House, Canberra

Invited clinician speaker addressing parliamentarians on IBD care and patient access

2026

Sandoz Medicines Access & Biosimilar Policy Summit, Canberra

Panellist representing GESA on national biosimilar prescribing access

2024

GESA AGW 2024, Adelaide

Invited speaker on intestinal ultrasound with live demonstration; announced as incoming IBD Faculty Chair-Elect

Selected Publications

79 peer-reviewed publications · 2,576+ Google Scholar citations · Research focus: IBD, intestinal ultrasound, mitochondrial DAMPs, biomarkers, AI in healthcare

Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications

Boyapati RK, Rossi AG, Satsangi J, Ho GT · Mucosal Immunology, 2016

Biomarkers in Search of Precision Medicine in IBD

Boyapati RK, Kalla R, Satsangi J, Ho GT · Am J Gastroenterol, 2016

Systematic review of effects of withdrawal of immunomodulators or biologics from IBD patients

Torres J*, Boyapati RK* et al · Gastroenterology, 2015 · *Joint first author

Integrative epigenome-wide analysis demonstrates DNA methylation may mediate genetic risk in IBD

Ventham NT, Kennedy NA, Adams AT, Kalla R... Boyapati RK · Nature Communications, 2016

Advances in the understanding of mitochondrial DNA as a pathogenic factor in inflammatory diseases

Boyapati RK, Tamborska A, Dorward DA, Ho GT · F1000Research, 2017

Dr Ray Boyapati keynote presentation at Digital Health Festival 2026

Keynote — Digital Health Festival 2026

Work With Me

Available for speaking engagements, advisory boards, media commentary, research collaboration, and expert consultancy & mentorship.

Speaking & Keynotes

Conferences, panels, and expert commentary on IBD, AI in healthcare, digital health, entrepreneurship, clinician & patient advocacy, and medical entrance preparation.

Digital Healthcare & AI

Clinical governance and safety, clinical workflow integration, AI model validation, and strategic advisory for digital health companies and health systems.

Research Collaboration

IBD clinical trials, intestinal ultrasound studies, biomarker research, and international collaborations.

Media & Commentary

Expert opinion on gastroenterology, healthcare AI, medical education policy, and clinician & patient advocacy.

Consultancy & Mentorship

Expert individual or group consultancy and mentorship for medical entrance, entrepreneurship, and digital health. Fees apply.

Send a Message

My team will respond within 2–3 business days.